The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
Open accessAbstract
Interleukin 10 (IL-10) and viral IL-10 (v-IL-10) strongly reduced antigen-specific proliferation of human T cells and CD4+ T cell clones when monocytes were used as antigen-presenting cells. In contrast, IL-10 and v-IL-10 did not affect the proliferative responses to antigens presented by autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific T cell responses was associated with downregulation of constitutive, as well as interferon gamma- or IL-4-induced, class II MHC expression on monocytes by IL-10 and v-IL-10, resulting in the reduction in antigen-presenting capacity of these cells. In contrast, IL-10 and v-IL-10 had no effect on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigen-presenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular Ca2+ in the responder T cell clones. The diminished antigen-presenting capacities of monocytes were not due to inhibitory effects of IL-10 and v-IL-10 on antigen processing, since the proliferative T cell responses to antigenic peptides, which did not require processing, were equally well inhibited. Furthermore, the inhibitory effects of IL-10 and v-IL-10 on antigen-specific proliferative T cell responses could not be neutralized by exogenous IL-2 or IL-4. Although IL-10 and v-IL-10 suppressed IL-1 alpha, IL-1 beta, tumor necrosis factor alpha (TNF-alpha), and IL-6 production by monocytes, it was excluded that these cytokines played a role in antigen-specific T cell proliferation, since normal antigen-specific responses were observed in the presence of neutralizing anti-IL-1, -IL-6, and -TNF-alpha mAbs. Furthermore, addition of saturating concentrations of IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha to the cultures had no effect on the reduced proliferative T cell responses in the presence of IL-10, or v-IL-10. Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T cell proliferation by inhibition of the antigen-presenting capacity of monocytes through downregulation of class II MHC antigens on monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Expression and secretion of type beta transforming growth factor by activated human macrophages.
Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6020 · Cited by 970
Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., deVries, J. E., Roncarolo, M. G., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 739
Self-citationStructure and Function of Leukocyte Integrins
Larson, R. S., & Springer, T. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00565.x · Cited by 599
Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1
Hsu, D.-H., Malefyt, R. D. W., Fiorentino, D. F., Dang, M.-N., Vieira, P., deVries, J., Spits, H., Mosmann, T. R., & Moore, K. W. (1990) · Science · doi:10.1126/science.2173142 · Cited by 535
Self-citationSimultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.
Paliard, X., de Waal Malefijt, R., Yssel, H., Blanchard, D., Chrétien, I., Abrams, J., de Vries, J., & Spits, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.849 · Cited by 512
Self-citationInterleukin 10: a novel stimulatory factor for mast cells and their progenitors.
Thompson-Snipes, L., Dhar, V, Bond, M. W., Mosmann, T. R., Moore, K. W., & Rennick, D. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.507 · Cited by 495
Scheurich, P., Thoma, B., Ucer, U., & Pfizenmaier, K. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1786 · Cited by 492
Cited by
Items 101–144 of 144
Velupillai, P., & Harn, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.18 · Cited by 299
New insights into the molecular mechanism of interleukin-10-mediated immunosuppression
Grütz, G. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904484 · Cited by 296
Phenotypic characterization of human decidual macrophages
HEIKKINEN, J., MÖTTÖNEN, M., KOMI, J., ALANEN, A., & LASSILA, O. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02092.x · Cited by 293
The yin and yang of evasion and immune activation in HCC
Makarova-Rusher, O. V., Medina-Echeverz, J., Duffy, A. G., & Greten, T. F. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.038 · Cited by 293
King, C. L., Mahanty, S., Kumaraswami, V, Abrams, J. S., Regunathan, J., Jayaraman, K., Ottesen, E. A., & Nutman, T. B. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116752 · Cited by 292
Human interleukin-10 can directly inhibit T-cell growth
Taga, K., Mostowski, H., & Tosato, G. (1993) · Blood · doi:10.1182/blood.v81.11.2964.2964 · Cited by 291
The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain
Donnelly, R. P., Sheikh, F., Kotenko, S. V., & Dickensheets, H. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0204117 · Cited by 289
Interferon gamma inhibits interleukin 10 production by monocytes.
Chomarat, P., Rissoan, M. C., Banchereau, J., & Miossec, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.523 · Cited by 287
Malhotra, I., Mungai, P., Wamachi, A., Kioko, J., Ouma, J. H., Kazura, J. W., & King, C. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6843 · Cited by 286
Brockman, M. A., Kwon, D. S., Tighe, D. P., Pavlik, D. F., Rosato, P. C., Sela, J., Porichis, F., Le Gall, S., Waring, M. T., Moss, K., et al. (2009) · Blood · doi:10.1182/blood-2008-12-191296 · Cited by 286
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Sato, T., Terai, M., Tamura, Y., Alexeev, V., Mastrangelo, M. J., & Selvan, S. R. (2011) · Immunologic Research · doi:10.1007/s12026-011-8262-6 · Cited by 286
Cacciarelli, T. V., Martinez, O. M., Gish, R. G., Villanueva, J. C., & Krams, S. M. (1996) · Hepatology · doi:10.1002/hep.510240102 · Cited by 284
Foey, A. D., Parry, S. L., Williams, L. M., Feldmann, M., Foxwell, B. M. J., & Brennan, F. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.920 · Cited by 283
Chen, X., Zhou, B., Li, M., Deng, Q., Wu, X., Le, X., Wu, C., Larmonier, N., Zhang, W., Zhang, H., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.11.009 · Cited by 283
Tr1 cells: From discovery to their clinical application
Battaglia, M., Gregori, S., Bacchetta, R., & Roncarolo, M.-G. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.007 · Cited by 279
Self-citationIn Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice
Turner, J., Gonzalez-Juarrero, M., Ellis, D. L., Basaraba, R. J., Kipnis, A., Orme, I. M., & Cooper, A. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6343 · Cited by 277
Buelens, C., Willems, F., Delvaux, A., Piérard, G., Delville, J., Velu, T., & Goldman, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250940 · Cited by 274
IL‐10 and IL‐10 receptor defects in humans
Glocker, E., Kotlarz, D., Klein, C., Shah, N., & Grimbacher, B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06339.x · Cited by 272
Tilg, H., van Montfrans, C., van den Ende, A., Kaser, A., van Deventer, S. J. H., Schreiber, S., Gregor, M., Ludwiczek, O., Rutgeerts, P., Gasche, C., et al. (2002) · Gut · doi:10.1136/gut.50.2.191 · Cited by 272
Brightbill, H. D., Plevy, S. E., Modlin, R. L., & Smale, S. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1940 · Cited by 268
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044002 · Cited by 263
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors
Gerber, J. S., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6861 · Cited by 263
Viral immune evasion: a masterpiece of evolution
Vossen, M. T., Westerhout, E. M., Söderberg-Nauclér, C., & Wiertz, E. J. (2002) · Immunogenetics · doi:10.1007/s00251-002-0493-1 · Cited by 261
Hong, Y. H., Lillehoj, H. S., Lillehoj, E. P., & Lee, S. H. (2006) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2006.08.006 · Cited by 261
Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis
Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R. O., Maini, R. N., & Feldmann, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390318 · Cited by 261
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Isomäki, P., & Punnonen, J. (1997) · Annals of Medicine · doi:10.3109/07853899709007474 · Cited by 260
Regulatory NK Cells Suppress Antigen-Specific T Cell Responses
Deniz, G., Erten, G., Kücüksezer, U. C., Kocacik, D., Karagiannidis, C., Aktas, E., Akdis, C. A., & Akdis, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.850 · Cited by 256
Pilette, C., Nouri-Aria, K. T., Jacobson, M. R., Wilcock, L. K., Detry, B., Walker, S. M., Francis, J. N., & Durham, S. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4658 · Cited by 256
Stowell, S. R., Qian, Y., Karmakar, S., Koyama, N. S., Dias-Baruffi, M., Leffler, H., McEver, R. P., & Cummings, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3091 · Cited by 255
IFN-γ: A cytokine at the right time, is in the right place
Burke, J. D., & Young, H. A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.05.002 · Cited by 254
Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239
Katiyar, S. K., Challa, A., McCormick, T. S., Cooper, K. D., & Mukhtar, H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2117 · Cited by 193
Immune dysregulation in the aging human lung
Meyer, K. C., Ershler, W., Rosenthal, N. S., Lu, X. G., & Peterson, K. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.3.8630547 · Cited by 173
Schönemeyer, A., Lucius, R., Sonnenburg, B., Brattig, N., Sabat, R., Schilling, K., Bradley, J., & Hartmann, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3207 · Cited by 155
Interleukin‐10, Polymorphism in SLC11A1(formerly NRAMP1), and Susceptibility to Tuberculosis
Awomoyi, A. A., Marchant, A., Howson, J. M. M., McAdam, K. P. W. J., Blackwell, J. M., & Newport, M. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/345920 · Cited by 153
“IL-10 down-regulates MHC class II expression on monocytes, thereby preventing antigen-specific T cell proliferation [40].”
BackgroundEndotoxemia contributes to the immune paralysis in patients with cirrhosis
Lin, C.-Y., Tsai, I.-F., Ho, Y.-P., Huang, C.-T., Lin, Y.-C., Lin, C.-J., Tseng, S.-C., Lin, W.-P., Chen, W.-T., & Sheen, I.-S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.12.018 · Cited by 145
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1104-5 · Cited by 138
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions
Laurent, S., Carrega, P., Saverino, D., Piccioli, P., Camoriano, M., Morabito, A., Dozin, B., Fontana, V., Simone, R., Mortara, L., et al. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.07.007 · Cited by 121
Parasite-specific immunomodulatory functions of filarial cystatin
Schierack, P., Lucius, R., Sonnenburg, B., Schilling, K., & Hartmann, S. (2003) · Infection and Immunity · doi:10.1128/iai.71.5.2422-2429.2003 · Cited by 119
Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration
Goverdhan, S. V., Ennis, S., Hannan, S. R., Madhusudhana, K. C., Cree, A. J., Luff, A. J., & Lotery, A. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.123190 · Cited by 79
Gray, C. P., Franco, A. V., Arosio, P., & Hersey, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1269 · Cited by 70
Mumm, J. B., & Oft, M. (2013) · BioEssays · doi:10.1002/bies.201300004 · Cited by 53
TLR7 and TLR9 ligands regulate antigen presentation by macrophages
Celhar, T., Pereira-Lopes, S., Thornhill, S. I., Lee, H. Y., Dhillon, M. K., Poidinger, M., Connolly, J. E., Lim, L. H. K., Biswas, S. K., & Fairhurst, A.-M. (2016) · International Immunology · doi:10.1093/intimm/dxv066 · Cited by 52
CHADBAN, TESCH, FOTI, LAN, ATKINS, & NIKOLIC‐PATERSON (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00487.x · Cited by 44
Metadata
- Authors
- de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1991-10-01
- Volume
- 174
- Issue
- 4
- Pages
- 915-924
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2101771134
- Cited by
- 1,930
- References
- 28
- FWCI
- 25.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.